Pharmacogenomics and Clinical Genomics

Pharmacogenomics  is the study of the role of genetics in drug response. Computational advances in Pharmacogenomics has proven to be a blessing in research. A large amount of research in the biomedical sciences regarding Pharmacogenomics as of late stems from combinatorial chemistry,[53] genomic mining, omic technologies and high throughput screening. In order for the field to grow rich knowledge enterprises and business must work more closely together and adopt simulation strategies. Major Universities dealing Pharmacogenomics are:  Harvard University, US, , University of Cambridge, UK, National University of Singapore, Singapore, University of Oxford, UK, Karolinska Institute, Sweden, Monash University, Australia, Imperial College London, UK, University of Tokyo, Japan, University of Melbourne, Australia, University of Michigan, US.

  • Translational Pharmacogenomics
  • Applications of NGS to Pharmacogenomics
  • Nutrigenomics
  • Toxicogenomics
  • Biomarker translation and testing
  • Biological and small molecule therapeutics
  • Molecular-targeted interventions including gene therapy
  • Molecular diagnostics
  • Pharmacogenomics
  • Cancer Pharmacogenomics
  • Pharmacogenitics & Individualized therapy
  • Pharmacogenomics in Clinical Therapeutics

Related Conference of Pharmacogenomics and Clinical Genomics

November 30-30, 2020

Genetics and Molecular biology

Paris, France
December 07-08, 2020

2nd World Congress on Cell and Structural Biology

Sydney, Australia
December 09-09, 2020

International Conference on Toxicogenomics

Bali, Indonesia

Pharmacogenomics and Clinical Genomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in